EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Circ_0110498 facilitates the cisplatin resistance of non‐small cell lung cancer by mediating the miR ‐1287‐5p/ RBBP4 axis

Dexun Hao, Yanshuang Li, Jiang Shi, Junguang Jiang iD

Thoracic Cancer · 2023

DOI: 10.1111/1759-7714.14787 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, 2023. Verfasst von Dexun Hao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Respiratory and Sleep, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Drug Resistance, Neoplasm, MicroRNAs, Retinoblastoma-Binding Protein 4. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Circular RNAs (circRNAs) play vital roles in non‐small cell lung cancer (NSCLC) progression. Our research analyzed the role of circ_0110498 on the cisplatin (DDP) resistance of NSCLC.

Methods

Cell glycolysis was analyzed by measuring glucose consumption and lactate production. Protein expression was determined by western blot analysis. The expression of circ_0110498, microRNA (miR)‐1287‐5p and RBBP4 was detected by RT‐qPCR assay. Cell counting kit‐8, colony formation and transwell assays, together with flow cytometry were conducted to analyze cell DDP resistance, proliferation, metastasis and apoptosis.

Results

Circ_0110498 expression was elevated in DDP‐resistant NSCLC tissues and cells. Circ_0110498 silencing not only suppressed the DDP resistance of NSCLC cells by inhibiting cell growth, metastasis and glycolysis, but also enhanced the DDP sensitivity of NSCLC tumors. MiR‐1287‐5p was sponged by circ_0110498, and its inhibitor also reversed the effect of circ_0110498 silencing on the DDP resistance of NSCLC cells. MiR‐1287‐5p interacted with RBBP4, and RBBP4 overexpression partly reversed the inhibitory effect of miR‐1287‐5p on the DDP resistance of NSCLC cells.

Conclusion

Circ_0110498 facilitated DDP resistance partly through mediating the miR‐1287‐5p/RBBP4 signaling in NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungDrug Resistance, NeoplasmMicroRNAsRetinoblastoma-Binding Protein 4RNA, CircularHumansCell Line, TumorCell ProliferationCisplatinLactic AcidLung Neoplasms

Stichwörter der Autor:innen

RBBP4circ_0110498cisplatinmiR-1287-5pnon-small cell lung cancer

Substanzen

CisplatinLactic AcidMicroRNAsMIRN1287 microRNA, humanRBBP4 protein, humanRetinoblastoma-Binding Protein 4RNA, Circular

Autor:innen und Institutionen

  • Department of Geriatric Respiratory and Sleep, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China.
  • Department of Anesthesiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China.

ORCID-Profile: Junguang Jiang

Zitieren

APA

Hao, D., Li, Y., Shi, J., & Jiang, J. (2023). Circ_0110498 facilitates the cisplatin resistance of non‐small cell lung cancer by mediating the miR ‐1287‐5p/ RBBP4 axis. Thoracic Cancer. https://doi.org/10.1111/1759-7714.14787

Vancouver

Hao D, Li Y, Shi J, Jiang J. Circ_0110498 facilitates the cisplatin resistance of non‐small cell lung cancer by mediating the miR ‐1287‐5p/ RBBP4 axis. Thoracic Cancer. 2023. doi:10.1111/1759-7714.14787

BibTeX
@article{Hao2023,
  author = {Hao, Dexun and Li, Yanshuang and Shi, Jiang and Jiang, Junguang},
  title = {Circ_0110498 facilitates the cisplatin resistance of non‐small cell lung cancer by mediating the miR ‐1287‐5p/ RBBP4 axis},
  journal = {Thoracic Cancer},
  year = {2023},
  doi = {10.1111/1759-7714.14787}
}
Kostenlos starten →